Brewin Dolphin Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1K	Hold	37	–	–	﹤0.01%	332
2022 Q1	$2K	Hold	37	–	–	﹤0.01%	352
2021 Q4	$2K	Hold	37	–	–	﹤0.01%	315
2021 Q3	$2.77K	Hold	37	–	–	﹤0.01%	324
2021 Q2	$3.42K	Hold	37	–	–	﹤0.01%	323
2021 Q1	$3.28K	Sell	37 -63	-63%	-$6.25K	﹤0.01%	313
2020 Q4	$9.33K	Buy	+100	New	+$7.97K	﹤0.01%	250

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Brewin Dolphin Wealth Management's ARKG Position: Q2 2022 in Review

Brewin Dolphin Wealth Management held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2022 at 37 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #332.

Brewin Dolphin Wealth Management first reported a position in ARKG in Q4 2020 and has held it in 7 quarters since. The position peaked at $9.33K in Q4 2020. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

Brewin Dolphin Wealth Management held 37 shares of ARK Genomic Revolution ETF worth $1K as of Q2 2022.
Brewin Dolphin Wealth Management left its ARK Genomic Revolution ETF share count unchanged in Q2 2022.
ARK Genomic Revolution ETF made up ﹤0.01% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #332 holding.
Brewin Dolphin Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 7 quarters since.
Brewin Dolphin Wealth Management's ARK Genomic Revolution ETF position peaked at $9.33K in Q4 2020.
333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.